Answers are grounded in this paper and cite their sources.
Correlation of the anticoagulant potency of plasmin digests of fibrinogen with the concentration of the recognized degradation products in the digests indicated that the high molecular weight fibrinogen Fragments X and Y, described in the accompanying article, were more potent anticoagulants than the end stage Fragments D and E. Findings in crude digests were corroborated by studies of the relative activity of individual purified degradation products as anticoagulants in a thrombin time system. Evidence was obtained by analytical ultracentrifugation that complexes formed chiefly between fibrin monomer and the degradation products, but also between Fragment X and other degradation products both before and after the addition of thrombin. Some of the complexes were not clottable by thrombin; others were clotted slowly. The nonclottable complexes composed of fibrin monomer and degradation products appeared to be primarily responsible for the hemorrhagic tendency of patients with fibrinolytic syndromes.
No takes yet. Share an insight, caveat, or question.
Marder et al. (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: